Introduction: In Portugal, a colorectal cancer screening program based on faecal immunochemical test followed by colonoscopy was shown to be cost-effective for individuals between 50 and 74 years old. We report the first findings of the implementation of a population-based program In Northern Portugal.Material and Methods: In the pilot phase, eligible subjects were allocated either to a direct mailing invitation or to primary care centers. In the first year of program implementation, we assessed the uptake rate, the faecal immunochemical test -positivity rate, the diagnostic yield of advanced neoplasia, and the quality parameters for post-faecal immunochemical test + colonoscopy.Results: We invited 100 501 eligible subjects (49% male with a median age of 55 years). Of these, 5228 participated in the pilot phase and 95 273 participated in the first year of the program. In the first year of the program, the adherence was 29%, with a positivity rate of 5% and a 60% compliance to colonoscopy. The faecal immunochemical test-detection rate of advanced neoplasia was 0.35/1000 subjects, and the positive predictive value at post- faecal immunochemical test + colonoscopy was 44% and 2% for advanced adenoma and invasive cancer, respectively. No major adverse events were reported after colonoscopy.Discussion: The suboptimal adherence to faecal immunochemical test and post-faecal immunochemical test + colonoscopy remains the most urgent step to be addressed.Conclusion: A centralized invitation system based on direct mailing was feasible and both colonoscopy quality and diagnostic yield were adequate antecipating the success of the programme.
RESUMOA tecnologia assistiva é um recurso indispensável para pessoas portadoras de deficiência, visto o benefício auferido na qualidade de vida e inclusão na sociedade desses indivíduos. Por meio da análise cienciométrica, o objetivo do presente estudo foi de avaliar a produção científica sobre a temática nos últimos oito anos, nas bases Scielo, PubMed e na Biblioteca Virtual de Saúde (BVS), nas línguas portuguesa e inglesa. Foram selecionados 33 artigos, dos quais a maior concentração ocorreu em 2017. O estado de São Paulo destacou-se pela maior quantidade de publicações e quanto ao periódico, evidenciou-se a Revista Brasileira de Educação Especial. Em termos de classificação Qualis/Capes, prevaleceu o estrato A1 e B1. Quanto a classificação por tipo de deficiência e por público alvo, houve dificuldade em definilas por apresentaram maior prevalência nos itens "outros" e "não consta". Concluiuse que a tecnologia assistiva é ainda pouco explorada no âmbito da pesquisa, e ainda assim, observando-se a dificuldade quanto às classificações por tipo de deficiência e público alvo. São relativamente escassos os artigos publicados sobre a temática. PALAVRAS-CHAVE: pessoa com deficiência, publicações, tecnologia assistiva. ANALYSIS OF SCIENTIFIC PRODUCTION ON ASSISTIVE TECHNOLOGY IN BRAZILABSTRACT Assistive technology is an indispensable resource for people with disabilities, given the benefit they have on the quality of life and inclusion in society of these individuals. The objective of the present study was to evaluate the scientific production on the subject in the last eight years, in the bases Scielo, PubMed and in the Virtual Health Library (VHL), in the Portuguese and English languages. A total of 33 articles were selected, of which the highest concentration occurred in 2017. The state of São Paulo stood out due to the greater number of publications and as for the periodical, it was evidenced the Brazilian Journal of Special Education. In terms of Qualis / Capes classification, stratum A1 and B1 prevailed. Regarding the
On page 168, Table 2, where it reads:On page 168, Table 2, where it reads:Advanced phenotype rate* [n (%)] 35 (49.0) 10 (52.0) 25 (47.0) 0.606Carcinoma** [n (%)] 2 (2.0) 1 (5.0) 1 (2.0)It should read:Advanced phenotype rate [n (%)] 179 (22.0) 57 (30.0) 35 (21.0) 29 (21.0) 24 (14.0) 34 (24.0)Carcinoma [n (%)] 3 (0.4) 2 1On page 168, Table 3, where it reads:ADR (%) 80.0 -Advanced adenoma (%) 44.0 15.9It should read:ADR (%) 41.0 -Advanced adenoma (%) 22.0 15.9 Article published with errors: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/15904
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.